Insider Trading

Michael F Maclean Net Worth

Track Major Insider Updates On X/Twitter

Last Updated: 1 week, 1 day ago

Michael F Maclean has an estimated net worth of at least $15.8 million*, as of Dec. 18, 2024. They own 82,942 shares of RNA stock. They have sold 361,069 shares of RNA stock since 2021, for an estimated $12.6 million.

Michael F Maclean $RNA SEC Form 4 Insider Trading

Michael F Maclean has filed a total of 10 insider trades in $RNA since 2021. Their most recent trade was a sale of 11,151 shares, made on Dec 18, 2024. Their largest trade was a sale of 104,245 shares, made on Jun 12, 2024. We estimate that they now own 82,942 shares of $RNA, worth an estimated $3.1 million.



Insider Trading at $RNA

There have been a total of 81 insider trades reported at $RNA since 2021, with 800,000 shares purchased and 2.0 million shares sold. The most active insider traders in $RNA stock have been Sarah Boyce, Arthur A Levin, and Michael F Maclean. The most recent trade was a sale of 12,742 shares reported by W. Michael Flanagan (CSTO), made on Dec 18, 2024.



History of Insider Stock Trades by Michael F Maclean

Company Ticker Purchase / Sale Shares Date Disclosed (EST)
RNA Sale 11,151 Dec 18, 2024 Dec. 19, 2024, 7:16 p.m.
RNA Sale 27,262 Nov 06, 2024 Nov. 8, 2024, 5:50 p.m.
RNA Sale 65,182 Nov 06, 2024 Nov. 8, 2024, 5:50 p.m.
RNA Sale 13,875 Nov 06, 2024 Nov. 8, 2024, 5:50 p.m.
RNA Sale 11,510 Sep 23, 2024 Sept. 23, 2024, 8:59 p.m.
RNA Sale 11,228 Jun 18, 2024 June 20, 2024, 6:48 p.m.
RNA Sale 104,245 Jun 12, 2024 June 14, 2024, 7:07 p.m.
RNA Sale 75,000 May 14, 2024 May 16, 2024, 6:25 p.m.
RNA Sale 40,000 Mar 13, 2024 March 15, 2024, 4:12 p.m.
RNA Sale 1,616 Jan 22, 2024 Jan. 23, 2024, 4:11 p.m.




$RNA Executives and Stock Owners with Insider Trades



*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.